PembrolizumabHypersensitivity reaction, lack of efficacy and infection: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1948卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35913-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：356 / 356

相关论文

共 50 条

[1] ImmunosuppressantsCytomegalovirus infection and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2037 (1) : 209 - 209
[2] ImmunosuppressantsSevere infection and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2046 (1) : 203 - 203
[3] InfliximabHypersensitivity reaction and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1836 (1) : 414 - 414
[4] AntineoplasticsGastrointestinal reaction and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2046 (1) : 43 - 43
[5] TocilizumabAllergic reaction and lack of efficacy: 2 case reports
Reactions Weekly, 2020, 1831 (1) : 269 - 269
[6] Propranolol/sirolimusLung infection and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1974 (1) : 301 - 301
[7] AntineoplasticsInvasive fungal infection and lack of efficacy: 2 case reports
Reactions Weekly, 2025, 2044 (1) : 42 - 42
[8] Multiple drugsSaccharothrix infection and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1901 (1) : 355 - 355
[9] PrednisoloneSystemic fungal infection and lack of efficacy : 2 case reports
Reactions Weekly, 2024, 2019 (1) : 392 - 392
[10] Rituximab/tocilizumabAllergic reaction and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1912 (1) : 399 - 399

← 1 2 3 4 5 →